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Dysmenorrhea is a common gynecologic disorder affecting as many as 60% of menstruating women.\[[@ref1]\] Based on the pathology, dysmenorrhea has been classified as primary and secondary.\[[@ref2]\] Primary dysmenorrhea refers to menstrual pain without pelvic pathology. The pain of primary dysmenorrhea usually begins a few hours before or just after the onset of menstrual period and may last 48-72 h. The pain is similar to labor pain, with suprapubic cramping, and may be accompanied by lumbosacral backache, with pain radiating down the anterior thigh.\[[@ref1][@ref2][@ref3]\] Primary dysmenorrhea is not associated with recognizable pelvic pathology.\[[@ref3]\] It is caused due to prostaglandin compounds that cause the contraction of myometrium,\[[@ref1][@ref4][@ref5]\] and occurs in 50%-75% of women.\[[@ref6]\]

Dysmenorrhea represents a significant personal and public health problem. It is a common complaint of both adolescent and adult women. In the United States, work absenteeism due to dysmenorrhea is estimated to be 600 million work hours per year, and the economic consequences are estimated at \$2 billion per year,\[[@ref7]\] therefore, it is a public problem nowadays.\[[@ref8]\]

A research in Sweden showed that more than 72% of 19-year-old women complained of primary dysmenorrhea. Among those affected, 34% reported mild symptoms, 23% moderate, and 15% reported severe symptoms.\[[@ref7]\] In surveys conducted in Iran, the prevalence of primary dysmenorrhea has been reported to be 71%-85.5%.\[[@ref9][@ref10][@ref11][@ref12]\]

The different options and nutrition methods used for treating primary dysmenorrhea include: psychotherapy, transcutaneous electrical nerve stimulation (TENS), vitamins, and medicines such as prostaglandin inhibitors, non-steroid anti-inflammatory drugs (NSAIDs), and contraception pills.\[[@ref13]\]

Prostaglandin synthase inhibitors, or NSAIDs (such as Ibuprofen), are effective for the treatment of primary dysmenorrhea, but the medication may be contraindicated in patients with gastrointestinal ulcers or bronchospastic hypersensitivity to aspirin. Side effects are usually mild, and include nausea, dyspepsia, diarrhea, and occasionally fatigue.\[[@ref1]\]

On the other hand, the use of plants accompanied with synthetic drugs can help to treat the disease. In Iran, folk herbal remedies can be used for healing of dysmenorrhea (such as fennel, chamomile, and marigold). Fennel (*Foeniculum vulgare Mill*) is an umbelliferous plant.\[[@ref14]\] Both the seed and extract of this plant are appetizing, digestive, diuretic, increased health, menstrative, anti-spasmodic, lactigenic, and laxative.\[[@ref15][@ref16][@ref17]\]

The study that compared the effect of oral fennel effect and mefenamic acid on primary dysmenorrhea reported no significant difference between them.\[[@ref18]\]

The probably effect of fennel might be related to the anti-spasmodic property of this plant. Anethole, the major fragrant in fennel seed, is similar in properties.

Nowadays, vitamins play an important role in the treatment of dysmenorrhea. Studies have shown this property with dopamine. It has been shown that anethole joins with dopamine receptors and decreases pain.\[[@ref19][@ref20][@ref21][@ref22]\] Use of these products has no adverse effect of tranquilizers.\[[@ref23]\] Vitamin E relieves primary dysmenorrhea, and probably its antioxidant property can suppress the oxidation of arachidonic acid, decreasing the production of prostaglandin.\[[@ref24][@ref25][@ref26]\] Iaghmaii *et al*. reported that vitamin E/mefenamic acid provided grater pain relief than mefenamic acid alone.\[[@ref27]\] The aim of this survey was to evaluate the efficacy of fennel extract/vitamin E compared with ibuprofen in the treatment of primary dysmenorrhea, with due attention to the different mechanisms of vitamin E and fennel extract (vitamin E is an antioxidant, and anethole in the extract of fennel is anti-spasmodic).
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This study was a double-blinded, cross-over study. The samples were female students of Tabriz University and Tabriz University of Medical Science, who suffered from primary dysmenorrhea. Inclusion criteria were having a history of primary dysmenorrhea, with regular menses in the last 3 months prior to the first visit, and no previous history of gynecologic disease and of allergy to NSAIDs, or suspected contraindication to herbal remedies, no history of pelvic major surgery, seizure, stressor factor in the last 6 months, severe gastrointestinal disorders, or any diseases that might interfere with the conduct of the study or the interpretation of the results. Exclusion criteria were having pain in the Duration of the menstruation period or before the onset of menstrual bleeding, use of oral hormonal contraception during treatment, having urinary tract infection in the study period, simultaneous participation in another clinical trial or participation in another clinical trial prior to study entry that might have an impact on the study objectives at the discretion of the investigator. The data were collected by using Visual Analogue Scale (VAS; questionnaire number 1, 2). For validation of the questionnaire, we used content validity that was conducted by 10 academic members of Tabriz University of Medical Science. For questionnaire reliability, test-retest was used. This study was undertaken with approval of the Tabriz University and Tabriz University of Medical Science ethics committee. Students who had the criteria for admission, and want to participate in the trial were asked to give their informed consent. The questionnaires were distributed to the students, and they were asked to fill them up. They were asked about demographic characteristics, menstrual health, general health, and intensity of menstruation pain. The researchers requested the participants who completed the questionnaire in the next month without use of any drugs. After that, the eligible students were determined; every student was randomly (Systematic Random Sampling) assigned to fennel/vitamin E group or ibuprofen group (34 participants in each group). For both groups, questionnaires 1 and 2 and drug packages with randomization codes of A and B were dispensed. The shape, size, and color of the capsule of drugs were similar. The subjects were requested to record the intensity of menstrual pain by VAS at 1, 2, 3, 6, 12, 24, and 48 h after the onset of bleeding. The first group used package A in the first month and package B in the second month. The second group was treated by package B in the first month and package A in the second month. Packages A and B contained fennel extract/vitamin E and ibuprofen. The study was double-blinded, i.e. the researcher and students did not know which medication was administered.
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Data were analyzed using SPSS version 14. Decrease in pain on using fennel extract/vitamin E and ibuprofen was expressed as mean ± SD. Wilcoxon test was used to compare the pain intensity between the two groups. *P* value \<0.05 was considered as significant.
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The mean age of the respondents was 21.8 ± 2.5 years. The mean of menstrual cycle duration was 28.1 ± 1.5 days, and the mean age of menarche was 16.1 ± 1.7 years \[[Table 1](#T1){ref-type="table"}\].

###### 

Characteristics of the study population on entry to the trial
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In our study, we found that 60.3% of subjects had missed school or daily activities due to dysmenorrhea, 89.7% participants reported use of tranquilizers, and 22.1% had family history of dysmenorrhea. The mean of maximum pain intensity in the fennel/vitamin E group at 1, 2, 3, 6, 48 h after administration was lower than the mean of maximum pain intensity in the ibuprofen group, although fennel extract/vitamin E composition was significantly more potent than ibuprofen in the first and second hours \[[Table 2](#T2){ref-type="table"}\].

###### 

Results of comparison of the severity of dysmenorrhea before and after intervention in both groups and between groups
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This analysis includes 68 female students who suffered from dysmenorrhea. The mean age was 21.8 ± 2.5 years. In this study, the age of onset of menarche was 13.8 ± 1.3 years, the mean of menstrual cycle interval was 28.1 ± 1.5 days, and the mean of menstrual cycle duration was 5.9 ± 1.1 days. Our finding is in agreement with the findings of Norouzi *et al*. in Bushehr,\[[@ref28]\] Modarres Nejad *et al*. in Rafsanjan,\[[@ref18]\] and Ozgoli *et al*. in Tehran.\[[@ref29]\]

The age of menarche in this study was at least 11 years, and in Norouzi *et al*.\'s study conducted in Bushehr in 2003, it was reported to be 9 years (28). The age of dysmenorrhea onset was 16.1 ± 1.7 years, and in Modarres Nejad *et al*.\'s survey in Rafsanjan in 2006, it was 13.7 ± 1.1 years.\[[@ref18]\] Moreover, Tarke Zahrani and colleagues reported the age of onset of dysmenorrhea in Tehran to be 14.46 ± 1.43 years.\[[@ref30]\] The discrepancy between the age of menarche and the age of onset of dysmenorrhea that we reported and in the above-mentioned surveys may be due to the individual, social, and environmental differences. The mean of pain intensity score in this study was 6.5 ± 1.6, which is in agreement with that reported by Iaghmaii *et al*. in Zahedan in 2005.\[[@ref27]\]

The prevalence of use of tranquilizers before study was 89.7%. In another survey in Tehran (2007), 95.7% of the participants reported using another drug for pain relief in the case group and about 95.5% used these drugs in the control group.\[[@ref30]\] The mentioned survey results are similar with our findings. Our study found that the mean of maximum pain intensity in fennel/vitamin E group was lower than that of ibuprofen group at 1, 2, 3, 6, and 48 h, although based on Wilcoxon test, this difference was statistically significant only in the first and second hours. Fennel extract/vitamin E was more potent than ibuprofen at 1 and 2 h (*P* \< 0.03 and *P* \< 0.04, respectively). No randomized control trial has examined the efficacy of fennel/vitamin E on dysmenorrhea, but Iaghmaii *et al*. (2005) in Zahedan compared the effect of mefenamic acid and vitamin E with that of mefenamic acid alone on pain and their results are consistent with our findings. Results showed that the mean of maximum pain difference before and after treatment in the group receiving mefenamic acid and vitamin E was 48.5 ± 17.5, but in the group taking mefenamic acid and placebo, this scale was 25.9 ± 21, and the difference was significant (*P* \< 0.001).\[[@ref27]\] Also, Tarke Zahrani and colleagues and Namavar Jahromi *et al*.\'s results on the effect of *F. vulgare* on primary dysmenorrhea,\[[@ref30][@ref31]\] Modarres Nejad *et al*.\'s results of their study in Rafsanjan about the effect of *F. vulgare* and mefenamic acid on the intensity pain in primary dysmenorrhea,\[[@ref18]\] Farahmad *et al*.\'s study results about the effect of vitamin E and brufen on primary dysmenorrhea,\[[@ref32]\] Ziaei *et al*.\'s study results about the effect of vitamin E in the treatment of primary dysmenorrhea\[[@ref26]\] were similar to our findings.
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Combination of fennel extract/vitamin E is effective on decreasing the intensity of pain of primary dysmenorrhea and it is advised to those who cannot use chemical drugs.
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